UNIVERSITÀ DI PISA
CONFERENCE REGISTRATION
€ 375,00 + VAT 22%
Registration fee includes: conference kit, admission to all the scientific sessions, lunch and coffee breaks. It is possible to register
online on the Official Site: http://www.ipadcongress.com
CONFERENCE VENUE
SEPTEMBER 27, 2014
FIRENZE
Grand Hotel Baglioni
GRAND HOTEL BAGLIONI
Piazza Unità Italiana, 6 - Firenze ITALIA
www.hotelbaglioni.it
OFFICIAL LANGUAGE
English is the official language of the Conference. No simultaneous translation will be provided.
CONTINUING MEDICAL EDUCATIONS ( CME )
Italian CME credits will be requested.
Supported by unrestricted educational grants by
Organizing Secretariat
First Class S.r.l. Meetings and Conferences
Viale Italia, 173 - 57127 Livorno - Via Malasoma, 14/16 - 56121 Pisa - Italy - Ph: +39 0586 84 98 11 - Email: veronica.trastulli@fclassevents.com
WEBSITE http://www.ipadcongress.com
INTERNATIONAL CONFERENCE
ON NEW THERAPIES FOR DEMENTIA
AND PARKINSONIAN SYNDROMES
FACULTY
Giovanni Abbruzzese (Genova)
Alberto Albanese (Milano)
Alfredo Berardelli (Roma)
Valentina Berti (Firenze)
Ubaldo Bonuccelli (Viareggio)
The 2nd International Conference on New Therapies for Dementia and Parkinsonian
second edition after the first successful 2013 Conference in Pisa. The conference will bring together European experts of neurodegenerative diseases coming
from the academic world, hospital centres and pharmaceutical industry. The
Meeting will focus on the new possibilities of preclinical and early diagnosis, and
Alberto Costa (Roma)
on the more innovative pharmacological and non-pharmacological therapies.
G. Di Chiara (Cagliari)
The results of clinical trials will be evaluated and discussed, as well as on-going
Antonio Federico (Siena)
studies and the expected outcomes, drugs' pipeline, non-pharmacological
Laura Fratiglioni (Stockholm)
therapies, perspectives on biomarkers and on future diagnostic-therapeutic
Jean-Charles Lambert (Lille, France)
scenario and unmet needs of patients with dementia and parkinsonian syndromes.
Niccolò Marchionni (Firenze)
This highly condensed meeting will be repeated alternatively in Pisa and Florence
Massimo Musicco (Roma)
with the aim of becoming a reference mark on what's new in the field of therapies
Nicola Origlia (Pisa)
of neurodegenerative diseases.
Francesco Saverio Pavone (Firenze)
Sandro Sorbi - Ubaldo Bonuccelli
Congress Presidents
Leandro Provinciali (Ancona)
Alberto Pupi (Firenze)
Silvia Ramat (Firenze)
Gabriele Siciliano (Pisa)
Maria Grazia Spillantini (Cambridge, UK)
Massimo Stefani (Firenze)
Fabrizio Stocchi (Roma)
Fabrizio Tagliavini (Milano)
Gregor Wenning (Innsbruck, Austria)
Opening: S. Sorbi, U. Bonuccelli
09:00 - 10:30
Risk factors: what's new
Chairmen: A. Federico - L. Provinciali
Dementia: from observation to intervention - L. Fratiglioni
New frontiers in genetic studies - J. C. Lambert
C9orf72 repeat expansions in dementia
and extrapyramidal disorders - V. Silani
Coffee break
11:00 - 13:00
Chairman: M. Musicco
Entorhinal cortex as a model to study synaptic dysfunction
in Alzheimer’s disease - N. Origlia
Modelling Multiple System Atrophy: Update - G. Wenning
Synaptic dysfunction in synucleinopathies - M.G. Spillantini
Memory and Movement: the relationship between motor
symptom lateralization and cognitive performance - A. Costa
13:00 - 14:00 Lunch
Elio Scarpini (Milano)
Sandro Sorbi (Firenze)
08:45
Syndromes (ICDP) will take place in Florence on September 27, 2014: this is the
Giovanni Umberto Corsini (Pisa)
Vincenzo Silani (Milano)
Saturday September 27
International Conference on new Therapies for Dementia
and Parkinsonian Syndromes
LOCAL ORGANIZING COMMITTEE
Laura Bracco (Firenze)
Roberto Ceravolo (Pisa)
Camilla Ferrari (Firenze)
Gemma Lombardi (Firenze)
Benedetta Nacmias (Firenze)
Gloria Tognoni (Pisa)
14:00 - 14:30
Early diagnosis: neuroimaging biomarker
Chairman: S. Sorbi
Neuroimaging: new biomarkers for Alzheimer disease
and Parkinson disease - A. Pupi / V. Berti
14:30 - 15:30
Pharmacotherapeutical Strategies
Chairmen: G. Abbruzzese - G. Siciliano
Dopamine receptors: therapy of Parkinson's
disease - G. Di Chiara
Therapy of rare dementias - F. Tagliavini
15:30 - 18:30
New trials and new drugs
Emerging Therapeutical Strategies
Chairmen: A. Berardelli - A. Albanese
Clinical trials in dementia: problems
and prospectives - E. Scarpini
Clinical Trials in Parkinson's disease:
problems and prospectives - F. Stocchi
Coffee break
Deep Brain Stimulation: a critical review - S. Ramat
Oleuropein aglycone: a new possible long-term
treatment to reduce risk of neurodegeneration and
dementia in aged people - M. Stefani
From nanoword to the macro through the micro
F.S. Pavone
General discussion